Detalles de la búsqueda
1.
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia.
Blood
; 114(16): 3382-91, 2009 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19605849
2.
A new concept for the differential diagnosis and therapy of anaemia in cancer patients.
Support Care Cancer
; 19(2): 261-9, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20148270
3.
Bacillary angiomatosis.
J Dtsch Dermatol Ges
; 7(9): 767-69, 2009 Sep.
Artículo
en Inglés, Alemán
| MEDLINE | ID: mdl-19298547
4.
Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial.
Br J Haematol
; 143(2): 191-200, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18752593
5.
Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients.
Br J Haematol
; 141(5): 631-40, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18422779
6.
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.
J Cancer Res Clin Oncol
; 139(3): 499-508, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23184429
7.
A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma - long-term results of a multicenter observation study.
Leuk Lymphoma
; 50(5): 716-22, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19347767
8.
Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study.
J Clin Oncol
; 25(15): 1986-92, 2007 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17420513
9.
The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Blood
; 104(10): 3064-71, 2004 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15284112
Resultados
1 -
9
de 9
1
Próxima >
>>